Risk factors for prolonged length of hospital stay following elective hip replacement surgery: a retrospective longitudinal observational study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
21 Aug 2024
Historique:
medline: 23 8 2024
pubmed: 23 8 2024
entrez: 22 8 2024
Statut: epublish

Résumé

Our aim was to identify which patients are likely to stay in hospital longer following total hip replacement surgery. Longitudinal, observational study used routinely collected data. Data were collected from an NHS Trust in South-West England between 2016 and 2019. 2352 hip replacement patients had complete data and were included in analysis. Three measures of length of stay were used: a count measure of number of days spent in hospital, a binary measure of ≤7 days/>7 days in hospital and a binary measure of remaining in hospital when medically fit for discharge. The mean length of stay was 5.4 days following surgery, with 18% in hospital for more than 7 days, and 11% staying in hospital when medically fit for discharge. Longer hospital stay was associated with older age (OR=1.06, 95% CI 1.05 to 1.08), being female (OR=1.42, 95% CI 1.12 to 1.81) and more comorbidities (OR=3.52, 95% CI 1.45 to 8.55) and shorter length of stay with not having had a recent hospital admission (OR=0.44, 95% CI 0.32 to 0.60). Results were similar for remaining in hospital when medically fit for discharge, with the addition of an association with highest socioeconomic deprivation (OR=2.08, 95% CI 1.37 to 3.16). Older, female patients with more comorbidities and from more socioeconomically deprived areas are likely to remain in hospital for longer following surgery. This study produced regression models demonstrating consistent results across three measures of prolonged hospital stay following hip replacement surgery. These findings could be used to inform surgery planning and when supporting patient discharge following surgery.

Identifiants

pubmed: 39174061
pii: bmjopen-2023-078108
doi: 10.1136/bmjopen-2023-078108
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e078108

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Rebecca Wilson (R)

National Institute for Health and Care Research Applied Research Collaboration West (NIHR ARC West) at University Hospitals Bristol and Weston NHS Foundation Trust, University of Bristol, Bristol, UK rebecca.wilson@bristol.ac.uk.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Ruta Margelyte (R)

Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Maria Theresa Redaniel (MT)

National Institute for Health and Care Research Applied Research Collaboration West (NIHR ARC West) at University Hospitals Bristol and Weston NHS Foundation Trust, University of Bristol, Bristol, UK.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Emily Eyles (E)

National Institute for Health and Care Research Applied Research Collaboration West (NIHR ARC West) at University Hospitals Bristol and Weston NHS Foundation Trust, University of Bristol, Bristol, UK.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Tim Jones (T)

National Institute for Health and Care Research Applied Research Collaboration West (NIHR ARC West) at University Hospitals Bristol and Weston NHS Foundation Trust, University of Bristol, Bristol, UK.
Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Chris Penfold (C)

National Institute for Health and Care Research Applied Research Collaboration West (NIHR ARC West) at University Hospitals Bristol and Weston NHS Foundation Trust, University of Bristol, Bristol, UK.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Ashley Blom (A)

The University of Sheffield, Sheffield, UK.

Andrew Elliott (A)

Southmead Hospital, Bristol, UK.

Alison Harper (A)

National Institute for Health and Care Research Applied Research Collaboration South-West Peninsula (PenARC), University of Exeter, Exeter, UK.
Medical School, University of Exeter, Exeter, UK.

Tim Keen (T)

North Bristol NHS Trust, Westbury on Trym, Bristol, UK.

Martin Pitt (M)

National Institute for Health and Care Research Applied Research Collaboration South-West Peninsula (PenARC), University of Exeter, Exeter, UK.
Medical School, University of Exeter, Exeter, UK.

Andrew Judge (A)

Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH